Tampa, Florida – Cancer informatics provider Inspirata AI announced today that it has become a member of the Advarra Partner Program. As an inaugural API Gold partner, Inspirata AI will collaborate closely with Advarra’s engineering and support teams on ensuring out-of-the-box integrations between OnCore, an Advarra CTMS solution, and Trial Navigator, Inspirata AI’s fully automated, NLP-powered clinical trial matching offering.
The new partnership between the two companies will also result in significantly improved performance and an overall reduction in burden from an implementation standpoint to shared customers. This aligns with the two companies’ mutual emphasis on providing a streamlined, best-in-class customer experience, which leads to high customer satisfaction and quality patient experience.
“Inspirata AI recognizes Advarra’s market leadership position in supporting clinical trials among many innovative and established research organizations, including academic medical centers, NCI-designated cancer centers, and large hospital systems. According to some estimates, approximately 2/3 of industry trials are supported in one way or another by our new partner’s technology and services. This makes this partnership a natural fit for us, as we continue to grow the footprint of our Trial Navigator solution and expand our ability to identify, connect, and serve cancer patients,” said Satish Sanan, CEO and Chairman of Inspirata AI, Inc.
“We are excited to be able to develop a fully-fledged bidirectional interface between Trial Navigator and OnCore. Trial Navigator benefits from our powerful NLP engine, which has been proven effective in quality tests performed by the National Cancer Institute. It is also SOC 2 compliant and approved for the Epic App Orchard. Natively integrating with Advarra’s CTMS is a logical next step on our journey to provide the most versatile, capable and secure clinical trial matching experience to our customers,” added George Cernile, VP of Engineering at Inspirata AI, Inc.
About Inspirata AI
Using our native AI platform that is specifically optimized for oncology, Inspirata AI helps cancer programs identify reportable cancer cases in real time, directly from source documents from clinical systems including AP-LIS, Radiology and HER. Using our end-to-end cancer registry workflow automation solution, healthcare organizations can significantly improve their cancer data casefinding, data abstraction, reporting and data analytics in a single platform thus reducing manual burden, and gain earlier visibility into patients clinical data across their cancer care continuum.
Delivering 99% accuracy and actionable oncology intelligence, Inspirata AI transforms cancer registry operations from a traditional cost center into a strategic asset that can support oncology service line revenue growth, patient retention, accreditation readiness, research initiatives, and informed clinical and business decision-making. Trusted by many large healthcare organizations nationwide, Inspirata AI empowers cancer programs to maximize the value of their oncology data and remove duplicate data entry, enabling the service line to identify more patients quickly, retain more patients within their network, and improve patient outcomes across their cancer care journey.
Inspirata AI Contact:
Emil Mladenov
Vice President of Corporate and Digital Marketing
Email: emladenov@inspirata.com
Tel: +1-813-570-8914
